News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Mary Lou Smith

Articles by Mary Lou Smith

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

ByErica L. Mayer, MD, MPH,Mary Lou Smith,Annie Guérin,Dominick Latrémouille-Viau,Nisha C. Hazra,Yan Meng,Wendi Qu,Remi Bellefleur,Vaidyanathan Ganapathy,Liz Santarsiero,Robert Morlock,Maryam Lustberg

August 2nd 2024

Latest Updated Articles

Trending on CancerNetwork

Adding SBRT to Ipilimumab/Nivolumab Does Not Improve PFS in Advanced RCC

Potential Iberdomide Approval May Offer Another Choice in Multiple Myeloma

Molecular Interception: Discussing the Future of Surgery in Breast Cancer

Examining Pembrolizumab Combo Safety in High-Risk Prostate Cancer

Lessons From the Withdrawal of Atezolizumab in Metastatic TNBC